KCTD4

gene
On this page

Also known as bA321C24.3

Summary

KCTD4 (potassium channel tetramerization domain containing 4, HGNC:23227) is a protein-coding gene on chromosome 13q14.12-q14.13, encoding BTB/POZ domain-containing protein KCTD4 (Q8WVF5).

Predicted to enable identical protein binding activity. Predicted to be involved in protein homooligomerization.

Source: NCBI Gene 386618 — RefSeq curated summary.

At a glance

  • MANE Select transcript: NM_198404

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:23227
Approved symbolKCTD4
Namepotassium channel tetramerization domain containing 4
Location13q14.12-q14.13
Locus typegene with protein product
StatusApproved
AliasesbA321C24.3
Ensembl geneENSG00000180332
Ensembl biotypeprotein_coding
OMIM620638
Entrez386618

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000379108

RefSeq mRNA: 1 — MANE Select: NM_198404 NM_198404

CCDS: CCDS9396

Canonical transcript exons

ENST00000379108 — 2 exons

ExonStartEnd
ENSE000014797914519285345194754
ENSE000039205644520082445201045

Expression profiles

Bgee: expression breadth ubiquitous, 135 present calls, max score 93.13.

FANTOM5 (CAGE): breadth broad, TPM avg 1.8759 / max 271.3708, expressed in 351 samples.

FANTOM5 promoters (7 alternative TSS)

Promoter IDTPM avgSamples expressed
1370760.9352170
1370810.3283148
1370770.233691
1370800.203897
1370780.100346
2070230.04399
1370790.030811

Top tissues by expression

236 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047393.13gold quality
nucleus accumbensUBERON:000188292.16gold quality
amygdalaUBERON:000187687.84gold quality
caudate nucleusUBERON:000187386.51gold quality
temporal lobeUBERON:000187184.42gold quality
cartilage tissueUBERON:000241884.04gold quality
middle temporal gyrusUBERON:000277182.80gold quality
Ammon’s hornUBERON:000195482.60gold quality
putamenUBERON:000187482.27gold quality
entorhinal cortexUBERON:000272880.80gold quality
Brodmann (1909) area 46UBERON:000648379.92gold quality
endothelial cellCL:000011579.37gold quality
prefrontal cortexUBERON:000045179.13gold quality
corpus callosumUBERON:000233678.70gold quality
amniotic fluidUBERON:000017378.62gold quality
tibiaUBERON:000097978.55gold quality
Brodmann (1909) area 9UBERON:001354078.24gold quality
forebrainUBERON:000189077.26gold quality
hypothalamusUBERON:000189876.84gold quality
epithelial cell of pancreasCL:000008376.77gold quality
anterior cingulate cortexUBERON:000983576.31gold quality
dorsolateral prefrontal cortexUBERON:000983476.06gold quality
cerebral cortexUBERON:000095676.04gold quality
frontal cortexUBERON:000187075.77gold quality
neocortexUBERON:000195074.71gold quality
trigeminal ganglionUBERON:000167574.70gold quality
right frontal lobeUBERON:000281074.62gold quality
C1 segment of cervical spinal cordUBERON:000646973.85gold quality
pigmented layer of retinaUBERON:000178273.36gold quality
tibial nerveUBERON:000132373.28gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.12

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

99 targeting KCTD4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4776-3P100.0068.731340
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-3646100.0073.565283
HSA-MIR-450A-1-3P100.0069.331837
HSA-MIR-4476100.0068.182030
HSA-MIR-126-5P100.0072.713180
HSA-MIR-607799.9968.042299
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-548P99.9872.253784
HSA-MIR-477599.9875.006394
HSA-MIR-27A-3P99.9872.132955
HSA-MIR-27B-3P99.9872.132955
HSA-MIR-998599.9872.112939
HSA-MIR-569699.9872.364487
HSA-MIR-314899.9775.066478
HSA-MIR-551B-5P99.9671.283493
HSA-MIR-590-3P99.9674.346478
HSA-MIR-1468-3P99.9672.743797
HSA-MIR-545-3P99.9570.742783
HSA-MIR-128-3P99.9571.172484
HSA-MIR-216A-3P99.9571.192505
HSA-MIR-144-3P99.9473.982698
HSA-MIR-9983-3P99.9471.483631
HSA-MIR-101-3P99.9475.032230
HSA-MIR-335-3P99.9373.364958
HSA-MIR-6768-5P99.9267.361942
HSA-MIR-3140-3P99.8868.472069
HSA-MIR-3681-3P99.8870.462254
HSA-MIR-129-5P99.8870.263273
HSA-MIR-579-3P99.8671.663628

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriokctd4ENSDARG00000068691
mus_musculusKctd4ENSMUSG00000046523
rattus_norvegicusKctd4ENSRNOG00000050996
drosophila_melanogastertwzFBGN0034636
caenorhabditis_elegansF32B4.5WBGENE00009315

Paralogs (13): KCTD1 (ENSG00000134504), KCTD14 (ENSG00000151364), KCTD15 (ENSG00000153885), KCTD18 (ENSG00000155729), KCTD6 (ENSG00000168301), KCTD19 (ENSG00000168676), KCTD12 (ENSG00000178695), KCTD16 (ENSG00000183775), KCTD8 (ENSG00000183783), KCTD21 (ENSG00000188997), KCNRG (ENSG00000198553), KCTD11 (ENSG00000213859), KCTD7 (ENSG00000243335)

Protein

Protein identifiers

BTB/POZ domain-containing protein KCTD4Q8WVF5 (reviewed: Q8WVF5)

All UniProt accessions (1): Q8WVF5

RefSeq proteins (1): NP_940686* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000210BTB/POZ_domDomain
IPR003131T1-type_BTBDomain
IPR011333SKP1/BTB/POZ_sfHomologous_superfamily
IPR045740KCTD4_CDomain

Pfam: PF02214, PF19323

UniProt features (4 total): chain 1, domain 1, region of interest 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8WVF5-F181.520.50

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 94 (showing top): FREAC3_01, RIGGI_EWING_SARCOMA_PROGENITOR_DN, NKX25_01, AACTTT_UNKNOWN, IK2_01, GOBP_PROTEIN_HOMOOLIGOMERIZATION, LEF1_Q6, WHN_B, AML1_01, FOX_Q2, chr13q14, YATGNWAAT_OCT_C, PR_01, KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN, MARTENS_TRETINOIN_RESPONSE_UP

GO Biological Process (1): protein homooligomerization (GO:0051260)

GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
protein complex oligomerization1
protein binding1
binding1

Protein interactions and networks

STRING

478 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
KCTD4CBY2Q8NA61605
KCTD4GTF2F2P13984551
KCTD4LDB2O43679482
KCTD4KCTD20Q7Z5Y7466
KCTD4GIGYF2Q6Y7W6426
KCTD4WDFY2Q96P53412
KCTD4TULP2O00295402
KCTD4PROSER2Q86WR7401
KCTD4KIAA1191Q96A73394
KCTD4BTBD19C9JJ37389
KCTD4FAM43BQ6ZT52359
KCTD4BTBD10Q9BSF8347
KCTD4KLHL34Q8N239340
KCTD4HTR2AP28223339
KCTD4GGA1Q9UJY5339

IntAct

28 interactions, top by confidence:

ABTypeScore
EFHC1KCTD4psi-mi:“MI:0915”(physical association)0.720
TAE1KCTD4psi-mi:“MI:0915”(physical association)0.560
SRP1KCTD4psi-mi:“MI:0915”(physical association)0.560
KCTD4TAE1psi-mi:“MI:0915”(physical association)0.560
KCTD4SRP1psi-mi:“MI:0915”(physical association)0.560
KCTD4DAXXpsi-mi:“MI:0915”(physical association)0.560
KCTD4NTAQ1psi-mi:“MI:0915”(physical association)0.560
KCTD4KCTD4psi-mi:“MI:0915”(physical association)0.550
KCTD4FERpsi-mi:“MI:0915”(physical association)0.490
KCTD4TNS4psi-mi:“MI:0915”(physical association)0.370
FXR2KCTD4psi-mi:“MI:0915”(physical association)0.370
STX17A2ML1psi-mi:“MI:0914”(association)0.350
OR2A4A2ML1psi-mi:“MI:0914”(association)0.350
CCR1UBA6psi-mi:“MI:0914”(association)0.350
DAXXKCTD4psi-mi:“MI:0915”(physical association)0.000
EFHC1KCTD4psi-mi:“MI:0915”(physical association)0.000
NTAQ1KCTD4psi-mi:“MI:0915”(physical association)0.000

BioGRID (16): KCTD4 (Two-hybrid), KCTD4 (Two-hybrid), KCTD4 (Two-hybrid), KCTD4 (Two-hybrid), KCTD4 (Two-hybrid), KCTD4 (Two-hybrid), KCTD4 (Two-hybrid), KCTD4 (Two-hybrid), KCTD4 (Affinity Capture-Western), KCTD4 (Proximity Label-MS), KCTD4 (Two-hybrid), KCTD4 (Two-hybrid), DAXX (Two-hybrid), KCTD4 (Affinity Capture-MS), KCTD4 (Affinity Capture-MS)

ESM2 similar proteins: A1A5R8, A6H6X4, A9ULR9, B1WC97, B8JKF4, O15091, O70479, P93002, Q0VFV7, Q12259, Q13829, Q28DC9, Q2HJ48, Q2T9W0, Q3TUL7, Q3URF8, Q4G0X4, Q5EAX2, Q5F3E8, Q5H9S7, Q5M956, Q5R4M2, Q5RBH4, Q5RD58, Q5XJ34, Q5ZJP7, Q68FF0, Q6DC02, Q6DCX3, Q6DFW0, Q6DG99, Q6NSI8, Q6P3P4, Q719H9, Q7TNY1, Q7TPL3, Q8BJK1, Q8BNL5, Q8NC69, Q8R4G8

Diamond homologs: A3KMV1, A4IFB4, A5PKG7, A6H6X4, B1WC97, B5DEL1, D5SHR0, G5EFC3, O65555, P0C5J9, P15388, P17971, P17972, P25122, P48547, P59994, P59995, Q01956, Q03607, Q03719, Q0VD00, Q0VFV7, Q14003, Q14681, Q29RJ0, Q2HJ48, Q2TUM3, Q3URF8, Q4G0X4, Q50H33, Q52PG9, Q54KH0, Q5DTY9, Q5M956, Q5XJ34, Q5ZJP7, Q62897, Q63881, Q63959, Q68DU8

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

211 predictions. Top by Δscore:

VariantEffectΔscore
13:45199942:G:GTdonor_gain0.9700
13:45194395:A:Tdonor_gain0.8500
13:45195339:A:ACacceptor_gain0.8200
13:45193040:G:GAdonor_gain0.8000
13:45195336:CTTA:Cacceptor_gain0.7900
13:45195340:A:Gacceptor_gain0.7900
13:45193062:ACCT:Adonor_gain0.7400
13:45194719:G:GGdonor_gain0.7400
13:45199964:GA:Gdonor_gain0.7400
13:45194718:A:AGdonor_gain0.7100
13:45198780:T:Gacceptor_gain0.7000
13:45199953:G:GAdonor_gain0.6800
13:45194560:C:CAacceptor_gain0.6700
13:45194760:G:GGdonor_gain0.6600
13:45197974:C:Tdonor_gain0.6500
13:45194759:A:AGdonor_gain0.6400
13:45193038:GTG:Gdonor_gain0.6300
13:45193037:AGT:Adonor_gain0.6200
13:45200408:A:AGdonor_gain0.6100
13:45194799:G:Tdonor_gain0.6000
13:45194415:C:Adonor_gain0.5900
13:45193044:CT:Cdonor_gain0.5800
13:45195430:ACTGT:Adonor_gain0.5600
13:45195469:GGAGA:Gdonor_gain0.5600
13:45193933:T:TAdonor_gain0.5500
13:45195338:TA:Tacceptor_gain0.5500
13:45195342:A:Gacceptor_gain0.5500
13:45193036:AAGT:Adonor_gain0.5400
13:45195466:ATAGG:Adonor_gain0.5400
13:45193375:A:Cacceptor_gain0.5300

AlphaMissense

1711 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
13:45194091:A:CC159W0.999
13:45194287:C:GR94P0.999
13:45194299:A:GL90P0.999
13:45193900:A:GL223P0.998
13:45193916:A:GC218R0.998
13:45193945:A:GL208P0.998
13:45194056:C:GR171P0.998
13:45194092:C:TC159Y0.998
13:45194093:A:GC159R0.998
13:45194228:C:GA114P0.998
13:45194290:A:GL93P0.998
13:45194311:A:GF86S0.998
13:45194320:C:TG83D0.998
13:45194323:T:AD82V0.998
13:45194326:C:AR81M0.998
13:45194438:A:CY44D0.998
13:45194449:C:AG40V0.998
13:45193798:A:GF257S0.997
13:45193804:A:GL255P0.997
13:45193876:G:TA231D0.997
13:45193889:C:GA227P0.997
13:45193914:A:CC218W0.997
13:45193920:A:CF216L0.997
13:45193920:A:TF216L0.997
13:45193922:A:GF216L0.997
13:45193939:A:GL210P0.997
13:45193981:A:GF196S0.997
13:45194239:A:GL110P0.997
13:45194324:C:GD82H0.997
13:45194452:A:TV39D0.997

dbSNP variants (sampled 300 via entrez): RS1000462647 (13:45199469 T>C), RS1001075032 (13:45192399 G>C), RS1001378215 (13:45199502 A>C), RS1001403268 (13:45200379 T>C), RS1001434546 (13:45200176 G>A), RS1002047937 (13:45198927 A>G), RS1002503118 (13:45202663 G>A), RS1002601325 (13:45202923 A>G), RS1002637628 (13:45193686 G>A,C), RS1003092459 (13:45196034 A>G,T), RS1003677370 (13:45195166 A>G), RS1003748215 (13:45201769 G>A), RS1003780867 (13:45201553 A>G), RS1004022988 (13:45198406 C>A), RS1004121315 (13:45198845 G>T)

Disease associations

OMIM: gene MIM:620638 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

13 total (human), top 13 by PubMed support.

ChemicalActions (top 5)PubMed papers
Nickeldecreases expression2
nickel sulfatedecreases expression1
perfluorooctane sulfonic acidincreases expression1
CGP 52608affects binding, increases reaction1
Benzo(a)pyreneaffects methylation1
Silicon Dioxideaffects expression1
Smokedecreases expression1
Thiramdecreases expression1
Tobacco Smoke Pollutionincreases expression1
Vanadatesincreases expression1
Asbestos, Crocidoliteaffects methylation1
Lactic Aciddecreases expression1
Magnetite Nanoparticlesincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.